| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267474.1 |
GSK1904529A |
Bladder urothelial carcinoma |
0.032554365 |
Resistant |
| ENSG00000267474.1 |
GSK1904529A |
Lung squamous cell carcinoma |
0.012265 |
Resistant |
| ENSG00000267474.1 |
GSK1904529A |
Colon adenocarcinoma |
0.047241187 |
Sensitive |
